NCT04767646

Brief Summary

The study evaluates the relationship between the duration of evolution of SDRC1 and the efficacy of continuous peripheral nerve block (c-PNB) associated with an intensive rehabilitation program to improve the therapeutic strategy of SDRC1. The main hypothesis of this study is that if c-PNB is proposed earlier, the recovery, measured with a scale achievement of objectives, will be better.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 23, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

February 23, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

4.9 years

First QC Date

February 5, 2021

Last Update Submit

April 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The composite score (the summation of the 3 Goal Attainment Scaling (GAS) scores)

    The improvement of the composite score following BNPc combined with intensive rehabilitation.

    1 year

Secondary Outcomes (13)

  • Pain assessment

    1 year

  • Anxiety assessment

    1 year

  • Arthrometry assessment

    1 year

  • hand joint assessment

    1 year

  • gripping force assessment

    1 year

  • +8 more secondary outcomes

Study Arms (1)

C-BNP with intensive rehabilitation program

EXPERIMENTAL
Procedure: Intensive rehabilitation program with CPNB

Interventions

The patient will have an intensive rehabilitation program (two 30-minute kinesitherapy sessions every day and 30-minute occupational therapy sessions 5 days a week) with the CPNB. The patient will have follow-up consultation at 1 month, 3 month, 6 month and 1 year after the beggining of the intensive rehabilitation program

C-BNP with intensive rehabilitation program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • informed consent signed
  • Diagnosis of CRPS type 1 according to BUDAPEST criteria to the upper or lower limb
  • Affiliated to a social security scheme (beneficiary or entitled person)
  • Patients justifying the installation of a Continuous Peripheral Nerve Block (CPNB) including pain rebellious to physical and medicinal treatments, the presence of fixed dystonia, or kinesiphobia or who are no longer progressing in the rehabilitation algorithm and requiring the need for a specialised technical platform.

You may not qualify if:

  • CRPS Type 2
  • Contra-indication to the analgesics used (bupivacaine, ropivacaine, levobupivacaine)
  • Severe psychiatric decompensation
  • Under legal protection measures
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pôle Saint Hélier

Rennes, Brittany Region, 35000, France

RECRUITING

MeSH Terms

Conditions

Complex Regional Pain Syndromes

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular Diseases

Study Officials

  • Philippe Gallien, Doctor

    Pôle Saint Hélier

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Philippe Gallien, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2021

First Posted

February 23, 2021

Study Start

February 23, 2021

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

April 9, 2025

Record last verified: 2025-04

Locations